Exvastat Ltd

Exvastat Ltd is a biotechnology company focused on developing treatments for Acute Respiratory Distress Syndrome (ARDS). Their product, Impentri™, is a formulation of imatinib that can be delivered intravenously, providing an option for patients unable to receive oral medications.

Treatment for ARDS
Pharmaceutical development
Impentri™ intravenous therapy

Size

Small

Phone

N/A

Website

exvastat.com

N/A

Locations

5 Tenison Ave, CB1 2DX

Digital Popularity

Social Media

Competitors

Sentinel Oncology

Sentinel Oncology is dedicated to discovering innovative cancer therapies, focusing on the development and commercialisation of new therapeutics for oncology and diseases with a high unmet need.

ET-traps Limited

ET-traps Limited is a pharmaceutical company focused on developing novel therapeutics that target pathologically elevated endothelin-1 levels in the body.

Company Details

Exvastat Ltd is operated by Exvastat Ltd and is a Dissolved company incorporated on 27 May 2016 with the registered office located in Huntingdon, Cambridgeshire. Exvastat Ltd was registered 9 years ago.

Status

Dissolved

Size

Micro

Directors

Age

9 years old

Employees

Turnover

Unreported

Total Assets

£324.72K